October Pharma

مادة اعلانية

Latest Update: 22 Dec 2024 16:06 Abu Dhabi Time.

Market Status: Closed

OCPH

October Pharma

101.00

EGP

-8.140

-7.46%

Open

109.14

Prev Close

109.14

PX_VOLUME

832

MARKET CAP (M)

DAY RANGE

100.58 - 104.00

52 WEEKS

83.02 - 166.99

Stock Statistics

Yearly Change

9.14%

Listed Shares (Million)

12.00

Earnings Multiple

7.88

Average 30-day trading volume

1,149.16

Price-to-book ratio

2.02

Earnings Per Share

15.18

Previous Dividend Distribution

Dividend Yield

2.29%

Financial Summary

Quarterly
Annual

Income Statements

	Period Ending:	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023
Total Revenue		326.08	285.42	274.41	307.28	263.15	228.57
Gross Profit		131.11	120.96	133.78	141.12	133.72	111.39
Operating Income		80.67	71.33	79.69	89.10	84.99	65.69
Profit Margin		9.83	11.43	18.27	16.73	18.63	17.50

	Period Ending:	Dec 31, 2023	Dec 31, 2022
Total Revenue	1,011.65	727.37
Gross Profit	498.29	356.90
Operating Income	308.82	203.40
Profit Margin	18.00	17.98

Balance Sheet

	Period Ending:	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023
Total Assets		1,469.26	1,329.25	1,242.70	1,138.09	1,097.10	1,024.88
Total Liabilities		820.64	712.67	603.03	548.55	558.96	535.75
Total Equity		648.62	616.58	639.67	589.54	538.14	489.13

	Period Ending:	Dec 31, 2023	Dec 31, 2022
Total Assets	1,138.09	950.08
Total Liabilities	548.55	524.55
Total Equity	589.54	425.52

Cash Flows Statements - Coming Soon

* In Million of Egypt Pound

Reminder: The financial information on this website is delayed information that are originates from certified data providers in the financial markets, who retain the rights and intellectual property of this data, absolving ADMN of any responsibility.